The U.S. blood pressure monitoring devices market size is projected to reach US$ 1.48 billion by 2033, indicating a CAGR of 11.10% from 2024 to 2033.

Key Takeaways

• By product, the sphygmomanometer segment held the largest share of the market in 2023.
• By product, the ambulatory blood pressure monitor segment is expected to witness the fastest rate of expansion during the forecast period of 2024-2033.
• By end user, the hospitals segment held the largest share of the market in 2023 and the segment is observed to grow at the fastest rate during the forecast period.
• By end user, the home healthcare segment is observed to grow at the fastest CAGR during the forecast period.

The U.S. Blood Pressure Monitoring Devices Market is a dynamic sector within the healthcare industry, focused on the development and distribution of devices that measure and monitor blood pressure. These devices play a crucial role in the management and prevention of cardiovascular diseases, a leading cause of morbidity and mortality in the United States. As the awareness of the importance of blood pressure monitoring continues to grow, the market for these devices is witnessing significant expansion.

Get a Sample: https://www.precedenceresearch.com/sample/3735

Growth Factors

Several factors contribute to the growth of the U.S. Blood Pressure Monitoring Devices Market. The aging population, increasing prevalence of hypertension, and a growing emphasis on preventive healthcare are key drivers. Advancements in technology, such as the integration of Bluetooth and smartphone compatibility in monitoring devices, have also fueled market expansion. Moreover, the rising adoption of home blood pressure monitoring by individuals for continuous health tracking has become a notable trend, further boosting market growth.

U.S. Blood Pressure Monitoring Devices Market Scope

Read More: Hydrogen Storage Tanks and Transportation Market Size, Report 2033

Opportunities

The market presents various opportunities for both existing and new players. Innovations in wearable technology for blood pressure monitoring, the development of smart and connected devices, and the integration of artificial intelligence for more accurate readings offer avenues for growth. Additionally, collaborations between healthcare providers and technology companies to enhance remote patient monitoring solutions provide a promising opportunity. The increasing focus on telehealth services amid the changing healthcare landscape further opens up possibilities for the market players to explore.

Challenges

Despite the promising prospects, the U.S. Blood Pressure Monitoring Devices Market faces certain challenges. Regulatory complexities, especially with regards to the accuracy and standardization of devices, pose obstacles for manufacturers. Additionally, issues related to reimbursement policies and the need for continuous education on proper device usage among end-users represent challenges. The market is also competitive, with companies vying to differentiate their products, which can be a hurdle for new entrants.

Reasons to Purchase this Report:

• Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
• In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
• Market size in USD million and volume in million units provided for each segment and sub-segment.
• Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
• Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

U.S. Blood Pressure Monitoring Devices Market Companies

• Koninklijke Philips N.V.
• General Electric Company
• SunTech Medical, Inc.
• Welch Allyn
• American Diagnostic Corporation
• Briggs Healthcare
• Spacelabs Healthcare
• GF HEALTH PRODUCTS, INC.
• Rossmax International Limited
• Microlife Corporation

Segments Covered in the Report

By Product

• Digital Blood Pressure Monitor
  • Wrist
  • Arm
  • Finger
• Sphygmomanometer
• Ambulatory Blood Pressure Monitor
• Instruments & Accessories
  • Blood pressure cuffs
    • Reusable
    • Disposable
  • Others
• Transducers
  • Reusable
  • Disposable

By End User

• Ambulatory Surgical Centers & Clinics
• Hospitals
• Home Healthcare

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Blood Pressure Monitoring Devices Market 

5.1. COVID-19 Landscape: U.S. Blood Pressure Monitoring Devices Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8.U.S. Blood Pressure Monitoring Devices Market, By Product

8.1. U.S. Blood Pressure Monitoring Devices Market Revenue and Volume, by Product, 2024-2033

8.1.1. Digital Blood Pressure Monitor

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Sphygmomanometer

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Ambulatory Blood Pressure Monitor

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Instruments & Accessories

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. Transducers

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. U.S. Blood Pressure Monitoring Devices Market, By End User

9.1. U.S. Blood Pressure Monitoring Devices Market Revenue and Volume, by End User, 2024-2033

9.1.1. Ambulatory Surgical Centers & Clinics

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Hospitals

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Home Healthcare

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. U.S. Blood Pressure Monitoring Devices Market and Trend Forecast

10.1. U.S.

10.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)

10.1.2. Market Revenue and Volume Forecast, by End User (2021-2033)

Chapter 11. Company Profiles

11.1. Koninklijke Philips N.V.

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. General Electric Company

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. SunTech Medical, Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Welch Allyn

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. American Diagnostic Corporation

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Briggs Healthcare

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Spacelabs Healthcare

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. GF HEALTH PRODUCTS, INC.

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Rossmax International Limited

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Microlife Corporation

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.autoindustrybulletin.com/